Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
89.99
-0.72 (-0.79%)
Sep 25, 2026, 2:00 PM EDT - Market open
Dianthus Therapeutics Employees
Dianthus Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 14 or 17.95% compared to the previous year.
Employees
92
Change (1Y)
14
Growth (1Y)
17.95%
Revenue / Employee
$20,696
Profits / Employee
-$2,089,630
Market Cap
5.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 92 | 14 | 17.95% |
| Dec 31, 2024 | 78 | 25 | 47.17% |
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Jun 30, 2023 | 43 | - | - |
| Mar 31, 2023 | 32 | - | - |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Iovance Biotherapeutics | 975 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Cogent Biosciences | 258 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
DNTH News
- 6 days ago - Dianthus files automatic mixed securities shelf - TheFly
- 14 days ago - Dianthus initiated with an Overweight at JPMorgan - TheFly
- 15 days ago - Dianthus Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 15 days ago - Dianthus Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 21 days ago - Dianthus initiated with a Buy at Citi - TheFly
- 22 days ago - Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Dianthus Therapeutics to Participate in Three Investor Conferences During September - GlobeNewsWire
- 7 weeks ago - Dianthus price target raised to $128 from $110 at Truist - TheFly